Related Experiment Video
Updated: Jul 29, 2025
08:37
Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
Published on: November 5, 2014
10.0K
MAP4K4 and cancer: ready for the main stage?
Jaime González-Montero1, Carlos I Rojas1, Mauricio Burotto1
1Bradford Hill Clinical Research Center, Santiago, Chile.
Frontiers in Oncology
|May 24, 2023
Summary
Mitogen-activated protein kinase kinase kinase 4 (MAP4K4) is crucial for development and implicated in metabolic diseases and cancer. Inhibiting MAP4K4 shows promise for treating various cancers by reducing tumor growth and spread.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- MAP4K4 is a serine/threonine kinase involved in embryogenesis and cell migration.
- Its dysregulation is linked to metabolic diseases and cancer initiation/progression.
- MAP4K4 knockout leads to embryonic lethality due to impaired somite development.
Purpose of the Study:
- To investigate the role of MAP4K4 in cancer development and progression.
- To evaluate MAP4K4 inhibition as a potential therapeutic strategy for various cancers.
Main Methods:
- Review of existing literature on MAP4K4 function.
- Analysis of in vitro studies using RNA interference (RNAi) for MAP4K4 knockdown.
- Examination of specific MAP4K4 inhibitors like GNE-495.
Main Results:
- MAP4K4 promotes tumor proliferation and invasion by activating pathways like JNK and MLK3.
- It also attenuates anti-tumor immune responses and enhances cell migration.
- RNAi-mediated MAP4K4 inhibition reduced tumor proliferation, migration, and invasion in vitro.
- Specific inhibitors like GNE-495 have been developed.
Conclusions:
- MAP4K4 plays a significant role in cancer initiation and progression.
- Inhibiting MAP4K4 function is a promising therapeutic strategy for cancers including pancreatic cancer, glioblastoma, and medulloblastoma.
- Further clinical testing of MAP4K4 inhibitors is warranted for cancer treatment.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:07MAPK Signaling Cascades
5.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
01:19Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K